Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric, Randomized Phase II Trial for the Treatment of Patients With Relapsed Osteosarcoma

NCT02718482 is registered in ClinicalTrials.gov with Italian Sarcoma Group as lead sponsor.

NCT NCT02718482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02718482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric, Randomized Phase II Trial for the Treatment of Patients With Relapsed Osteosarcoma
Lead sponsor
Italian Sarcoma Group
Phase
Phase 2
Overall status
Terminated
Start date
April 6, 2016
Completion date
January 7, 2019
Enrollment
7 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

osteosarcoma